Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Thomas J. Spencer, M.D.

Co-Author

This page shows the publications co-authored by Thomas Spencer and Stephen Faraone.
Connection Strength

10.404
  1. Importance of pharmacokinetic profile and timing of coadministration of short- and long-acting formulations of methylphenidate on patterns of subjective responses and abuse potential. Postgrad Med. 2012 Jan; 124(1):166-73.
    View in: PubMed
    Score: 0.503
  2. Effect of stimulants on height and weight: a review of the literature. J Am Acad Child Adolesc Psychiatry. 2008 Sep; 47(9):994-1009.
    View in: PubMed
    Score: 0.400
  3. Long-term effects of extended-release mixed amphetamine salts treatment of attention- deficit/hyperactivity disorder on growth. J Child Adolesc Psychopharmacol. 2005 Apr; 15(2):191-202.
    View in: PubMed
    Score: 0.315
  4. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005 Mar 01; 57(5):456-63.
    View in: PubMed
    Score: 0.313
  5. A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2002 Jul; 59(7):649-56.
    View in: PubMed
    Score: 0.261
  6. Overview and neurobiology of attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2002; 63 Suppl 12:3-9.
    View in: PubMed
    Score: 0.252
  7. Novel treatments for attention-deficit/hyperactivity disorder in children. J Clin Psychiatry. 2002; 63 Suppl 12:16-22.
    View in: PubMed
    Score: 0.252
  8. Toward operationalizing deficient emotional self-regulation in newly referred adults with ADHD: A receiver operator characteristic curve analysis. Eur Psychiatry. 2020 02 24; 63(1):e21.
    View in: PubMed
    Score: 0.221
  9. Informativeness of Self-Reports of ADHD Symptoms in Monitoring Response to Stimulant Treatment in Clinically Referred Adults With ADHD. J Atten Disord. 2020 02; 24(3):420-424.
    View in: PubMed
    Score: 0.196
  10. The Mixed Opioid Receptor Antagonist Naltrexone Mitigates Stimulant-Induced Euphoria: A Double-Blind, Placebo-Controlled Trial of Naltrexone. J Clin Psychiatry. 2018 Mar/Apr; 79(2).
    View in: PubMed
    Score: 0.193
  11. Opiate Antagonists Do Not Interfere With the Clinical Benefits of Stimulants in ADHD: A Double-Blind, Placebo-Controlled Trial of the Mixed Opioid Receptor Antagonist Naltrexone. J Clin Psychiatry. 2018 Jan/Feb; 79(1).
    View in: PubMed
    Score: 0.191
  12. Towards operationalising internal distractibility (Mind Wandering) in adults with ADHD. Acta Neuropsychiatr. 2017 Dec; 29(6):330-336.
    View in: PubMed
    Score: 0.190
  13. Is Paternal Smoking at Conception a Risk for ADHD? A Controlled Study in Youth With and Without ADHD. J Atten Disord. 2020 09; 24(11):1493-1496.
    View in: PubMed
    Score: 0.179
  14. Memantine in the Treatment of Executive Function Deficits in Adults With ADHD. J Atten Disord. 2017 02; 21(4):343-352.
    View in: PubMed
    Score: 0.173
  15. Mild Traumatic Brain Injury and Attention-Deficit Hyperactivity Disorder in Young Student Athletes. J Nerv Ment Dis. 2015 Nov; 203(11):813-9.
    View in: PubMed
    Score: 0.164
  16. Is Maternal Smoking During Pregnancy a Risk Factor for Cigarette Smoking in Offspring? A Longitudinal Controlled Study of ADHD Children Grown Up. J Atten Disord. 2017 Oct; 21(12):975-985.
    View in: PubMed
    Score: 0.154
  17. Attention-deficit/hyperactivity disorder and adverse health outcomes in adults. J Nerv Ment Dis. 2014 Oct; 202(10):725-31.
    View in: PubMed
    Score: 0.152
  18. Mild traumatic brain injury and ADHD: a systematic review of the literature and meta-analysis. J Atten Disord. 2014 Oct; 18(7):576-84.
    View in: PubMed
    Score: 0.150
  19. The Neuropsychological Profile of Comorbid Post-Traumatic Stress Disorder in Adult ADHD. J Atten Disord. 2016 12; 20(12):1047-1055.
    View in: PubMed
    Score: 0.146
  20. Effect of psychostimulants on brain structure and function in ADHD: a qualitative literature review of magnetic resonance imaging-based neuroimaging studies. J Clin Psychiatry. 2013 Sep; 74(9):902-17.
    View in: PubMed
    Score: 0.141
  21. Can pediatric bipolar-I disorder be diagnosed in the context of posttraumatic stress disorder? A familial risk analysis. Psychiatry Res. 2013 Aug 15; 208(3):215-24.
    View in: PubMed
    Score: 0.139
  22. Is ADHD a risk for posttraumatic stress disorder (PTSD)? Results from a large longitudinal study of referred children with and without ADHD. World J Biol Psychiatry. 2014 Jan; 15(1):49-55.
    View in: PubMed
    Score: 0.138
  23. Neuropsychological Deficits Are Not Predictive of Deficient Emotional Self-Regulation in Adults With ADHD. J Atten Disord. 2015 Dec; 19(12):1046-53.
    View in: PubMed
    Score: 0.137
  24. Posttraumatic stress disorder in adult attention-deficit/hyperactivity disorder: clinical features and familial transmission. J Clin Psychiatry. 2013 Mar; 74(3):e197-204.
    View in: PubMed
    Score: 0.136
  25. Understanding deficient emotional self-regulation in adults with attention deficit hyperactivity disorder: a controlled study. Atten Defic Hyperact Disord. 2013 Sep; 5(3):273-81.
    View in: PubMed
    Score: 0.136
  26. Functional genomics of attention-deficit/hyperactivity disorder (ADHD) risk alleles on dopamine transporter binding in ADHD and healthy control subjects. Biol Psychiatry. 2013 Jul 15; 74(2):84-9.
    View in: PubMed
    Score: 0.135
  27. Longitudinal course of deficient emotional self-regulation CBCL profile in youth with ADHD: prospective controlled study. Neuropsychiatr Dis Treat. 2012; 8:267-76.
    View in: PubMed
    Score: 0.130
  28. Preliminary examination of the reliability and concurrent validity of the attention-deficit/hyperactivity disorder self-report scale v1.1 symptom checklist to rate symptoms of attention-deficit/hyperactivity disorder in adolescents. J Child Adolesc Psychopharmacol. 2012 Jun; 22(3):238-44.
    View in: PubMed
    Score: 0.129
  29. Preliminary reliability and validity of a new time-sensitive ADHD symptom scale in adolescents with ADHD. Postgrad Med. 2011 Sep; 123(5):7-13.
    View in: PubMed
    Score: 0.123
  30. Toward defining deficient emotional self-regulation in children with attention-deficit/hyperactivity disorder using the Child Behavior Checklist: a controlled study. Postgrad Med. 2011 Sep; 123(5):50-9.
    View in: PubMed
    Score: 0.123
  31. Is response to OROS-methylphenidate treatment moderated by treatment with antidepressants or psychiatric comorbidity? A secondary analysis from a large randomized double blind study of adults with ADHD. CNS Neurosci Ther. 2012 Feb; 18(2):126-32.
    View in: PubMed
    Score: 0.122
  32. Dose response effects of lisdexamfetamine dimesylate treatment in adults with ADHD: an exploratory study. J Atten Disord. 2012 Feb; 16(2):118-27.
    View in: PubMed
    Score: 0.120
  33. Deficient emotional self-regulation and adult attention deficit hyperactivity disorder: a family risk analysis. Am J Psychiatry. 2011 Jun; 168(6):617-23.
    View in: PubMed
    Score: 0.120
  34. Are stimulants effective in the treatment of executive function deficits? Results from a randomized double blind study of OROS-methylphenidate in adults with ADHD. Eur Neuropsychopharmacol. 2011 Jul; 21(7):508-15.
    View in: PubMed
    Score: 0.119
  35. Reliability and validity of the Time-Sensitive ADHD Symptom Scale in adults. Compr Psychiatry. 2011 Nov-Dec; 52(6):769-73.
    View in: PubMed
    Score: 0.118
  36. A naturalistic 10-year prospective study of height and weight in children with attention-deficit hyperactivity disorder grown up: sex and treatment effects. J Pediatr. 2010 Oct; 157(4):635-40, 640.e1.
    View in: PubMed
    Score: 0.115
  37. Adult psychiatric outcomes of girls with attention deficit hyperactivity disorder: 11-year follow-up in a longitudinal case-control study. Am J Psychiatry. 2010 Apr; 167(4):409-17.
    View in: PubMed
    Score: 0.110
  38. Effects of lisdexamfetamine dimesylate treatment for ADHD on growth. J Am Acad Child Adolesc Psychiatry. 2010 Jan; 49(1):24-32.
    View in: PubMed
    Score: 0.110
  39. Effect of candidate gene polymorphisms on the course of attention deficit hyperactivity disorder. Psychiatry Res. 2009 Dec 30; 170(2-3):199-203.
    View in: PubMed
    Score: 0.109
  40. Presenting ADHD symptoms, subtypes, and comorbid disorders in clinically referred adults with ADHD. J Clin Psychiatry. 2009 Nov; 70(11):1557-62.
    View in: PubMed
    Score: 0.108
  41. Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study. Pediatrics. 2009 Jul; 124(1):71-8.
    View in: PubMed
    Score: 0.106
  42. Family based association study of pediatric bipolar disorder and the dopamine transporter gene (SLC6A3). Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 05; 147B(7):1182-5.
    View in: PubMed
    Score: 0.101
  43. New insights into the comorbidity between ADHD and major depression in adolescent and young adult females. J Am Acad Child Adolesc Psychiatry. 2008 Apr; 47(4):426-434.
    View in: PubMed
    Score: 0.097
  44. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry. 2008 May; 165(5):597-603.
    View in: PubMed
    Score: 0.097
  45. Stability of executive function deficits in girls with ADHD: a prospective longitudinal followup study into adolescence. Dev Neuropsychol. 2008; 33(1):44-61.
    View in: PubMed
    Score: 0.095
  46. Utility of an abbreviated questionnaire to identify individuals with ADHD at risk for functional impairments. J Psychiatr Res. 2008 Mar; 42(4):304-10.
    View in: PubMed
    Score: 0.090
  47. A laboratory driving simulation for assessment of driving behavior in adults with ADHD: a controlled study. Ann Gen Psychiatry. 2007 Jan 30; 6:4.
    View in: PubMed
    Score: 0.089
  48. Substance use among ADHD adults: implications of late onset and subthreshold diagnoses. Am J Addict. 2007; 16 Suppl 1:24-32; quiz 33-4.
    View in: PubMed
    Score: 0.089
  49. Comparing the efficacy of medications for ADHD using meta-analysis. MedGenMed. 2006 Oct 05; 8(4):4.
    View in: PubMed
    Score: 0.088
  50. Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid? Am J Psychiatry. 2006 Oct; 163(10):1720-9; quiz 1859.
    View in: PubMed
    Score: 0.087
  51. Treatment of ADHD with stimulant medications: response to Nissen perspective in the New England Journal of Medicine. J Am Acad Child Adolesc Psychiatry. 2006 Oct; 45(10):1147-1150.
    View in: PubMed
    Score: 0.087
  52. Psychopathology in females with attention-deficit/hyperactivity disorder: a controlled, five-year prospective study. Biol Psychiatry. 2006 Nov 15; 60(10):1098-105.
    View in: PubMed
    Score: 0.085
  53. Does prolonged therapy with a long-acting stimulant suppress growth in children with ADHD? J Am Acad Child Adolesc Psychiatry. 2006 May; 45(5):527-537.
    View in: PubMed
    Score: 0.085
  54. A double-blind comparison of galantamine hydrogen bromide and placebo in adults with attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychopharmacol. 2006 Apr; 26(2):163-6.
    View in: PubMed
    Score: 0.084
  55. Atomoxetine and adult attention-deficit/hyperactivity disorder: the effects of comorbidity. J Clin Psychiatry. 2006 Mar; 67(3):415-20.
    View in: PubMed
    Score: 0.084
  56. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med. 2006 Feb; 36(2):167-79.
    View in: PubMed
    Score: 0.084
  57. Efficacy of atomoxetine in adult attention-deficit/hyperactivity disorder: a drug-placebo response curve analysis. Behav Brain Funct. 2005 Oct 03; 1:16.
    View in: PubMed
    Score: 0.082
  58. Atomoxetine and stroop task performance in adult attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2005 Aug; 15(4):664-70.
    View in: PubMed
    Score: 0.081
  59. In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter. Biol Psychiatry. 2005 Jun 01; 57(11):1293-300.
    View in: PubMed
    Score: 0.080
  60. An open-label trial of risperidone in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol. 2005 Apr; 15(2):311-7.
    View in: PubMed
    Score: 0.079
  61. Attention-deficit/hyperactivity disorder in adults: a survey of current practice in psychiatry and primary care. Arch Intern Med. 2004 Jun 14; 164(11):1221-6.
    View in: PubMed
    Score: 0.075
  62. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2004 Feb; 24(1):24-9.
    View in: PubMed
    Score: 0.073
  63. Emergence of tics in children with ADHD: impact of once-daily OROS methylphenidate therapy. J Child Adolesc Psychopharmacol. 2004; 14(2):185-94.
    View in: PubMed
    Score: 0.072
  64. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry. 2003 Nov; 160(11):1919-28.
    View in: PubMed
    Score: 0.071
  65. Growth deficits and attention-deficit/hyperactivity disorder revisited: impact of gender, development, and treatment. Pediatrics. 2003 May; 111(5 Pt 1):1010-6.
    View in: PubMed
    Score: 0.069
  66. Attention-deficit/hyperactivity disorder in children and adolescents with obsessive-compulsive disorder: fact or artifact? J Am Acad Child Adolesc Psychiatry. 2002 Jan; 41(1):52-8.
    View in: PubMed
    Score: 0.063
  67. A General Framework for Assessing In vitro/In vivo Correlation as a Tool for Maximizing the Benefit-Risk Ratio of a Treatment Using a Convolution-Based Modeling Approach. CPT Pharmacometrics Syst Pharmacol. 2019 02; 8(2):97-106.
    View in: PubMed
    Score: 0.051
  68. The Relationship Between Executive Function Deficits and DSM-5-Defined ADHD Symptoms. J Atten Disord. 2020 01; 24(1):41-51.
    View in: PubMed
    Score: 0.050
  69. Are Adult ADHD Patients Good Informants of Their Symptoms? A Qualitative Literature Review of Concordance Between Clinician and Self-Report ADHD Symptoms. J Nerv Ment Dis. 2018 09; 206(9):739-743.
    View in: PubMed
    Score: 0.050
  70. Validation of the Expanded Versions of the Adult ADHD Self-Report Scale v1.1 Symptom Checklist and the Adult ADHD Investigator Symptom Rating Scale. J Atten Disord. 2019 08; 23(10):1101-1110.
    View in: PubMed
    Score: 0.048
  71. How Informative Are Self-Reported Adult Attention-Deficit/Hyperactivity Disorder Symptoms? An Examination of the Agreement Between the Adult Attention-Deficit/Hyperactivity Disorder Self-Report Scale V1.1 and Adult Attention-Deficit/Hyperactivity Disorder Investigator Symptom Rating Scale. J Child Adolesc Psychopharmacol. 2018 06; 28(5):339-349.
    View in: PubMed
    Score: 0.047
  72. The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5. JAMA Psychiatry. 2017 05 01; 74(5):520-527.
    View in: PubMed
    Score: 0.046
  73. The structure of adult ADHD. Int J Methods Psychiatr Res. 2017 03; 26(1).
    View in: PubMed
    Score: 0.045
  74. Examining the association between posttraumatic stress disorder and attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. J Clin Psychiatry. 2016 Jan; 77(1):72-83.
    View in: PubMed
    Score: 0.042
  75. Adult Outcome of ADHD: An Overview of Results From the MGH Longitudinal Family Studies of Pediatrically and Psychiatrically Referred Youth With and Without ADHD of Both Sexes. J Atten Disord. 2018 04; 22(6):523-534.
    View in: PubMed
    Score: 0.041
  76. A Familial Risk Analysis of Emotional Dysregulation: A Controlled Study. J Atten Disord. 2018 07; 22(9):848-854.
    View in: PubMed
    Score: 0.040
  77. Further evidence that severe scores in the aggression/anxiety-depression/attention subscales of child behavior checklist (severe dysregulation profile) can screen for bipolar disorder symptomatology: a conditional probability analysis. J Affect Disord. 2014 Aug; 165:81-6.
    View in: PubMed
    Score: 0.037
  78. Toward Defining the Neural Substrates of ADHD: A Controlled Structural MRI Study in Medication-Naïve Adults. J Atten Disord. 2015 Nov; 19(11):944-53.
    View in: PubMed
    Score: 0.036
  79. Intellectual performance and school failure in children with attention deficit hyperactivity disorder and in their siblings. J Abnorm Psychol. 1993 Nov; 102(4):616-623.
    View in: PubMed
    Score: 0.036
  80. Personal and familial correlates of bipolar (BP)-I disorder in children with a diagnosis of BP-I disorder with a positive child behavior checklist (CBCL)-severe dysregulation profile: a controlled study. J Affect Disord. 2013 May; 147(1-3):164-70.
    View in: PubMed
    Score: 0.033
  81. Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidate. J Pediatr. 2013 Jan; 162(1):22-7.e2.
    View in: PubMed
    Score: 0.033
  82. Further understanding of the comorbidity between Attention-Deficit/Hyperactivity Disorder and bipolar disorder in adults: an MRI study of cortical thickness. Psychiatry Res. 2012 Apr 30; 202(1):1-11.
    View in: PubMed
    Score: 0.032
  83. Severity of the aggression/anxiety-depression/attention child behavior checklist profile discriminates between different levels of deficits in emotional regulation in youth with attention-deficit hyperactivity disorder. J Dev Behav Pediatr. 2012 Apr; 33(3):236-43.
    View in: PubMed
    Score: 0.032
  84. Relationship of DAT1 and adult ADHD to task-positive and task-negative working memory networks. Psychiatry Res. 2011 Jul 30; 193(1):7-16.
    View in: PubMed
    Score: 0.030
  85. Gray matter alterations in adults with attention-deficit/hyperactivity disorder identified by voxel based morphometry. Biol Psychiatry. 2011 May 01; 69(9):857-66.
    View in: PubMed
    Score: 0.029
  86. Neural substrates of impaired sensorimotor timing in adult attention-deficit/hyperactivity disorder. Biol Psychiatry. 2010 Aug 15; 68(4):359-67.
    View in: PubMed
    Score: 0.029
  87. Representativeness of participants in a clinical trial for attention-deficit/hyperactivity disorder? Comparison with adults from a large observational study. J Clin Psychiatry. 2010 Dec; 71(12):1612-6.
    View in: PubMed
    Score: 0.029
  88. Effect of dopamine transporter gene (SLC6A3) variation on dorsal anterior cingulate function in attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2010 Mar 05; 153B(2):365-375.
    View in: PubMed
    Score: 0.028
  89. Examination of concordance between maternal and youth reports in the diagnosis of pediatric bipolar disorder. Bipolar Disord. 2009 May; 11(3):298-306.
    View in: PubMed
    Score: 0.026
  90. A preliminary study of dopamine D4 receptor genotype and structural brain alterations in adults with ADHD. . 2008 Dec 05; 147B(8):1436-41.
    View in: PubMed
    Score: 0.025
  91. The reliability and validity of self- and investigator ratings of ADHD in adults. J Atten Disord. 2008 May; 11(6):711-9.
    View in: PubMed
    Score: 0.024
  92. Assessing the validity of the Quality of Life Enjoyment and Satisfaction Questionnaire Short Form in adults with ADHD. J Atten Disord. 2008 Jan; 11(4):504-9.
    View in: PubMed
    Score: 0.023
  93. A randomized, placebo-controlled clinical trial of bupropion for the prevention of smoking in children and adolescents with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2007 Jul; 68(7):1094-101.
    View in: PubMed
    Score: 0.023
  94. Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD. . 2006 Dec 05; 141B(8):890-4.
    View in: PubMed
    Score: 0.022
  95. Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr. 2006 Aug; 11(8):625-39.
    View in: PubMed
    Score: 0.022
  96. Validity of pilot Adult ADHD Self- Report Scale (ASRS) to Rate Adult ADHD symptoms. Ann Clin Psychiatry. 2006 Jul-Sep; 18(3):145-8.
    View in: PubMed
    Score: 0.021
  97. Risperidone for the treatment of affective symptoms in children with disruptive behavior disorder: a post hoc analysis of data from a 6-week, multicenter, randomized, double-blind, parallel-arm study. Clin Ther. 2006 May; 28(5):794-800.
    View in: PubMed
    Score: 0.021
  98. Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community. J Clin Psychiatry. 2006 Apr; 67(4):524-40.
    View in: PubMed
    Score: 0.021
  99. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006 Apr; 163(4):716-23.
    View in: PubMed
    Score: 0.021
  100. New developments in the treatment of ADHD. J Clin Psychiatry. 2006 Jan; 67(1):148-59.
    View in: PubMed
    Score: 0.021
  101. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry. 2005 Jun 01; 57(11):1442-51.
    View in: PubMed
    Score: 0.020
  102. Training raters to assess adult ADHD: reliability of ratings. J Atten Disord. 2005 Feb; 8(3):121-6.
    View in: PubMed
    Score: 0.019
  103. Current concepts in the validity, diagnosis and treatment of paediatric bipolar disorder. Int J Neuropsychopharmacol. 2003 Sep; 6(3):293-300.
    View in: PubMed
    Score: 0.018
  104. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry. 2002 Jan; 159(1):36-42.
    View in: PubMed
    Score: 0.016
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.